Skip to Content

Proteonomix Inc PROT

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Proteonomix Inc develops pre-clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company focuses on developing therapeutics based upon the use of human cells and their derivative.

Contact
140 East Ridgewood Avenue, Suite 415
Paramus, NJ, 07652
T +1 973 949-4195
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Jun 30, 2012
Fiscal Year End Dec 31, 2012
Stock Type Distressed
Employees 2